Commitment COM-251
Post-approval commitment for TFDA-2024-0051. Category: REMS. Priority: medium.
Commitment ID
COM-251
Application
Authority
Taiwan Food and Drug Administration
Category
REMS
Priority
medium
Status
Open
Due Date
2025-09-02
Completed At
—
Owner
James O'Brien
Created
2023-06-10
Description
Provide carcinogenicity study report for 2-year rat study
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.